GlaxoSmithKline Fined $3 Billion For Healthcare Fraud
British drugmaker GlaxoSmithKline has agreed to pay $3 billion in fines to the U.S. Justice Department for misrepresenting drugs to consumers, reported Reuters on Monday, in what is believed to be the largest case of healthcare fraud in U.S. history.


